Image de couverture de livre

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Hyun‐Kyung Ko, Rebecca L. Foertsch, Kasen Shi, Janét Pittsenbarger, Changhui Xue, Kaiyo Shi, Hao Geng, Lina Gao, David Z. Qian
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Understanding Enzalutamide‐Resistance Based on a Functional Single‐Cell Approach
par: Changhui Xue, et autres
Publié: (2025)

Dorsomorphin Suppresses EMT to Reduce AR‐Negative Prostate Cancer Metastasis by Synergistically Antagonizing JAK2/STAT3 and Gli2‐Independent Shh Activation
par: Dongzhang Li, et autres
Publié: (2025)

Transcriptomic Signatures of Monocyte‐Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer
par: Marina Nasrin Sharifi, et autres
Publié: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
par: Yifu Shi, et autres
Publié: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
par: Erum Z. Whyne, et autres
Publié: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
par: Christian P. Pavlovich, et autres
Publié: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
par: Elizabeth Robinson, et autres
Publié: (2025)

Evaluating the Heterogeneity of Advanced Prostate Cancer by 18F‐DCFPyL and 18F‐FDG PET/CT in a Prospective Cohort
par: GuangHao Chen, et autres
Publié: (2025)

Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis
par: Lian Qiong, et autres
Publié: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
par: Tatsuya Shimomura, et autres
Publié: (2026)

Evidence and Rationale for Prostate Cancer Screening
par: Takeshi Takahashi
Publié: (2025)

Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity
par: Sara Darbandi, et autres
Publié: (2026)

Impact of the Nadir Androgen Receptor Signaling Inhibitor‐Derived Integrative Response Model in Real‐World Patients With Metastatic Castration‐Sensitive Prostate Cancer
par: Kazuma Yukihiro, et autres
Publié: (2026)

Altered Glycosylation of PSA in Prostate Cancer Tissue
par: Hannu Koistinen, et autres
Publié: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
par: Sheila Jonnatan, et autres
Publié: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
par: Andrea K. Miyahira, et autres
Publié: (2024)

Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
par: Mutlay Sayan, et autres
Publié: (2026)

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
par: Marco Oderda, et autres
Publié: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
par: Reid Vassallo, et autres
Publié: (2025)

Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real‐World Retrospective Study
par: Erum Z. Whyne, et autres
Publié: (2024)

Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
par: Kazuro Kikkawa, et autres
Publié: (2024)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
par: Charly Bâcle, et autres
Publié: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
par: Haotian Chen, et autres
Publié: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
par: Kristofer G. Taylor, et autres
Publié: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
par: Muhammad Umair, et autres
Publié: (2026)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
par: Hanna Zurl, et autres
Publié: (2025)

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment
par: Enyang He, et autres
Publié: (2024)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
par: Christian Andrés Martínez Osorio, et autres
Publié: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
par: Cameron J. Britton, et autres
Publié: (2025)

LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy
par: Sangjon Pae, et autres
Publié: (2025)

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study
par: Himawari Asanuma, et autres
Publié: (2026)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
par: Trevor C. Hunt, et autres
Publié: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
par: Andrea K. Miyahira, et autres
Publié: (2024)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
par: Marta Victoria Lorenzo‐Sánchez, et autres
Publié: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
par: Yu‐Hsiang Lin, et autres
Publié: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
par: Anwar E. Ahmed, et autres
Publié: (2025)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
par: Y. M. Yáñez‐Castillo, et autres
Publié: (2025)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
par: Anna‐Lena Lemster, et autres
Publié: (2025)

Outcome of Subsequent Therapies After 177Lu‐Vipivotide Tetraxetan for Metastatic Castrate‐Resistant Prostate Cancer: A Tertiary Cancer Center Experience
par: Meryam Losee, et autres
Publié: (2025)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
par: Fabian Falkenbach, et autres
Publié: (2025)